Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

Fluzone Quadrivalent

This page shows the latest Fluzone Quadrivalent news and features for those working in and with pharma, biotech and healthcare.

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi to pay $750m for vaccines biotech Protein Sciences

Sanofi’s vaccines portfolio already includes the four-in-one influenza vaccine Fluzone Quadrivalent, which the FDA approved in June 2013.

Latest news

  • AZ wins EU approval for four-strain flu vaccine AZ wins EU approval for four-strain flu vaccine

    It follows the approval earlier this year of GlaxoSmithKline's (GSK) four-strain, or quadrivalent, influenza vaccine Influsplit Tetra/Fluarix Tetra as pharma companies look to shift towards vaccines that provide ... Both AZ and GSK won approvals for

  • GSK gets OK for second quadrivalent flu vaccine in US GSK gets OK for second quadrivalent flu vaccine in US

    GSK joined the club when its Fluarix Quadrivalent was approved by the FDA last December, and since then Sanofi has also been given a green light for its Fluzone Quadrivalent, giving ... This year the WHO also made recommendations for quadrivalent

  • FDA approves Sanofi's four-in-one flu vaccine FDA approves Sanofi's four-in-one flu vaccine

    Sanofi Pasteur, the vaccines division of Sanofi, received a recommendation for its Fluzone Quadrivalent vaccine for use in children six months of age and older, adolescents, and adults to protect against ... According to Sanofi, the Fluzone Quadrivalent

  • GSK’s four-strain flu vaccine approved in Germany and UK GSK’s four-strain flu vaccine approved in Germany and UK

    GlaxoSmithKline (GSK) has been granted marketing approval in Germany and the UK for its four-strain (quadrivalent) influenza vaccine, the first registered product of its type in Europe. ... Sanofi Pasteur also has its own candidate, Fluzone Quadrivalent,

More from news
Approximately 1 fully matching, plus 4 partially matching documents found.

Latest Intelligence

  • Influenza – the risk to vulnerable populations Influenza – the risk to vulnerable populations

    and Fluzone High-Dose Quadrivalent (Influenza Vaccine) by Sanofi Pasteur and Fluad Quadrivalent(Influenza Vaccine, Adjuvanted) by CSL Seqirus UK. ... Fluad Quadrivalent contains an adjuvant called MF59 that is added to the vaccine to help boost the

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Subscribe to our email news alerts

PMHub

Add my company
KVA

KVA is an award winning full-service digital communications & brand experience agency. Our healthcare expertise blends creative ‘outside-the-box’ thinking with...

Latest intelligence

Healing the Healers
Because if we do not heal the healers, who is going to heal us?...
The (inevitable) digital transformation of Medical Affairs
It’s not a question of ‘if,’ it’s a question of ‘when.’...
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...

Quick links